Navigation Links
DuPont Tate & Lyle Bio Products Announces Innovation Award Program

Wilmington, Del. (PRWEB) January 03, 2013

DuPont Tate & Lyle Bio Products Company LLC today announces the launch of an Innovation Award program for companies using its Zemea® Propanediol in their cosmetic and personal care ingredients or formulations. Eligible nominees have either commercialized a finished product for retail or launched another ingredient that contains Zemea® Propanediol from Jan. 1, 2011 through Dec. 31, 2012.

Nominations are being accepted between Jan. 3 and Jan. 31, 2013. Nominations will be judged, compared and evaluated by a panel of experienced leaders in the cosmetics and personal care market. This year’s judges include Steve Herman, chair-elect of the New York Society of Cosmetic Chemists and adjunct professor at Fairleigh Dickinson University, Tom Branna, editor of HAPPI magazine, and Steve Hurff, vice president of marketing and sales, DuPont Tate & Lyle Bio Products. The winning company will be announced on Feb. 25, 2013, the timing to coincide with the Personal Care Products Council annual meeting in Palm Beach, Florida.

Complete details including the nomination form are included here as an attachment or can be downloaded from the company’s website at The winning company will receive an engraved plaque and a contribution of $1,500 will be made on its behalf to an approved charity of its choice.

Zemea® is a natural, 100 percent biobased ingredient made from corn sugar through fermentation and developed for use in the cosmetics and personal care market. It is a high-performance, environmentally sustainable alternative to petroleum-based glycols and glycerin, where the product’s lack of skin irritation, improved moisturization and excellent aesthetic properties are benefits. Zemea® is approved as a natural ingredient by Ecocert and the Natural Products Association; is certified 100 percent biobased by the U.S. Department of Agriculture and has both Kosher and Halal certifications.    

"We are excited to recognize innovative leaders in the cosmetics and personal care market who have chosen Zemea® for its unique and sustainable performance capabilities," said Steve Hurff, vice president of marketing and sales, DuPont Tate & Lyle Bio Products.

DuPont Tate & Lyle Bio Products is a joint venture between DuPont, a global science company, and Tate & Lyle, a world-leading renewable food and industrial ingredients company. DuPont Tate & Lyle Bio Products provides natural and renewably sourced ingredients that do not compromise product performance. For more information on the company’s products, visit

# # #

Zemea® and the circle logo are registered trademarks of DuPont Tate & Lyle Bio Products Company LLC.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. DuPont Leader Overviews 2012 Seed Research Pipeline with Investors
2. Piedmont Chemical Launches 100 Percent Renewable Polyester Polyols Leveraging Renewable Chemicals from DuPont Tate & Lyle Bio Products and Myriant Corporation
3. DuPont Congratulates David Hula for Highest Overall Yield with Pioneer® hybrid – P2088YHR in 2012 NCGA Corn Yield Contest
4. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
5. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
6. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
7. Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany
8. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
9. Fifth Cycle of Probiotics & Microbiota Research Grant Announced
10. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
11. Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D
Post Your Comments:
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of the ... brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing ... to its list of well-respected retailers. This list includes such fine stores as ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... FRANCISCO and BANGALORE, India , ... of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... provider, today announced a global partnership that will ... way to use mobile banking and payment services. ... is a key innovation area for financial services, but it ...
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
Breaking Biology News(10 mins):